Updated: Dec 9, 2021
OPEN INVITATION - Details below - Every Wednesday
Link to call Wednesday December 8th starting at 7:00-8:30 pm Central time
Note: This itinerary will be updated.
I will start the call discuss some of my thoughts on the Progenity:
Why I think they will be the dominant company in the oral drug delivery space
Why I think they will reach $1200 a share in 2032
Then open the floor up to questions and comments.
I will also make sure to record this call and leave it here after we conclude our discussion. Feel free to record it as well. (Transcript is on the very bottom of page for those who want to check it out)
Recorded call here, audio is what it is, but content is good.
SKIP TO 3 mins in!!! This is the raw unedited cut, very valuable information and points all the way through. Enjoy!
Examples below if you want to add content just message me!
[Title of your discussion] - [When you will speak - 7:00-7:15 pm]
[your name or nickname] [A link to where someone can find you]
If you want a picture or two for your reference and aid in discussion you can send it over to me via email email@example.com, or send it via twitter, I'll make sure to get it on here and make it look pretty.
Also, just send a short summary of what you will talk about, or bullet points.
To recap what I need from you to send to me via email or twitter:
Title of discussion
Link or place you'd prefer people to find you
Pictures or charts (not needed but if you want)
Bullet points of your discussion so listeners can follow along. If they'd like.
Introduction & Succinct Overview of Progenity's Products 7:15-7:30 pm
Brad Mitchell Optifinancialnews.com
OBDS | DDS | PIL DX
15% bio with initial product- 2022 - PK/PD data December PK/PD <- watch
JetCap comparison (they claim 50% bioavailability!!!) - compares and illustrates jet stream
Competition Overview (Look at Rani) 1.4 Billion as of writing, Prog valued at .44 Billion
Topics/Pictures from and submissions from the community (will update more if you send me after the call)
Research and findings from Mr Good Advisor Twitter - (@ChrisMaster700)
William Sandborne - a board member who is the leader in GI tract diseases has multiple connections to Pfizer, Abbvie (which are the rumoured partners/suitors) :
Pictures of screenshots below:
Pfizer connections of the Progenity Board member: